David Jin Yoo - Mar 23, 2023 Form 4 Insider Report for Bellevue Life Sciences Acquisition Corp. (BLAC)

Role
Chief Financial Officer
Signature
/s/ David Jin Yoo
Stock symbol
BLAC
Transactions as of
Mar 23, 2023
Transactions value $
$0
Form type
4
Date filed
3/27/2023, 04:06 PM
Previous filing
Feb 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLAC Common Stock Award $0 +20K $0.00 20K Mar 23, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLAC Warrant for Common Stock Award $0 +20K $0.00 20K Mar 23, 2023 Common Stock 20K $11.50 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the shares transferred by Bellevue Global Life Sciences Investors LLC, the sponsor of the Issuer (the "Sponsor"), to Mr. Yoo for his service as Chief Financial Officer.
F2 Represents the warrants to purchase a total of 20,000 shares of the Issuer, transferred from the Sponsor to Mr. Yoo for his service as Chief Financial Officer. Each warrant will become exercisable 30 days after the Issuer's initial business combination. Each warrant will expire five years after the completion of the Issuer's initial business combination, or earlier upon redemption or liquidation. Each warrant entitles the holder to purchase one share of common stock at a price of $11.50 per share, subject to adjustments.